Edition:
United Kingdom

Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

4.93USD
8:50pm BST
Change (% chg)

$0.11 (+2.28%)
Prev Close
$4.82
Open
$4.81
Day's High
$4.96
Day's Low
$4.80
Volume
115,930
Avg. Vol
253,151
52-wk High
$8.05
52-wk Low
$4.49

Latest Key Developments (Source: Significant Developments)

Cerus Says Entered Into Credit Agreement
Monday, 1 Apr 2019 

April 1 (Reuters) - Cerus Corp ::CERUS CORP SAYS ON MARCH 29, CO ENTERED INTO A CREDIT, SECURITY AND GUARANTY AGREEMENT - SEC FILING.CERUS CORP - TERM LOAN CREDIT AGREEMENT PROVIDES A SECURED TERM LOAN FACILITY IN AN AGGREGATE PRINCIPAL AMOUNT OF UP TO $70.0 MILLION.  Full Article

Cerus Expects Full Year 2018 Product Revenue To Be $60.9 Million
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Cerus Corp ::CERUS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2018 PRODUCT REVENUE.2019 PRODUCT REVENUE GUIDANCE OF $70 MILLION TO $73 MILLION.UNAUDITED PRELIMINARY PRODUCT REVENUE FOR Q4 OF 2018 TOTALED $16.5 MILLION.EXPECTS FULL YEAR 2018 PRODUCT REVENUE TO BE $60.9 MILLION.Q4 REVENUE VIEW $19.9 MILLION -- REFINITIV IBES DATA.FY2018 REVENUE VIEW $74.2 MILLION -- REFINITIV IBES DATA.  Full Article

Cerus Q3 Loss Per Share $0.11
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Cerus Corp ::ORATION REPORTS THIRD QUARTER 2018 RESULTS.Q3 LOSS PER SHARE $0.11.Q3 EARNINGS PER SHARE VIEW $-0.10 -- THOMSON REUTERS I/B/E/S.2018 PRODUCT REVENUE GUIDANCE REVISED UPWARDS TO A RANGE OF $58 MILLION TO $60 MILLION.PRODUCT REVENUE DURING Q3 OF 2018 WAS $15.4 MILLION, COMPARED TO $10.8 MILLION DURING SAME PERIOD IN 2017.Q3 REVENUE VIEW $20.0 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Cerus Corp Reports Q1 Loss Per Share $0.11
Tuesday, 8 May 2018 

May 8 (Reuters) - Cerus Corp ::ORATION REPORTS FIRST QUARTER 2018 RESULTS.Q1 LOSS PER SHARE $0.11.Q1 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S.RAISING FULL YEAR PRODUCT REVENUE GUIDANCE RANGE TO $53 MILLION TO $55 MILLION FROM $51 MILLION TO $53 MILLION.PRODUCT REVENUE FOR Q1 OF 2018 WAS $13.6 MILLION, COMPARED TO $7.0 MILLION.FY2018 REVENUE VIEW $67.9 MILLION -- THOMSON REUTERS I/B/E/S.Q1 REVENUE VIEW $14.3 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Cerus Corp Expects Full Year 2017 Product Revenue To Be $43.6 Million
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Cerus Corp ::CERUS CORP - CERUS' UNAUDITED PRELIMINARY PRODUCT REVENUE FOR Q4 OF 2017 WAS $16.2 MILLION.CERUS CORP - UNAUDITED PRELIMINARY PRODUCT REVENUE FOR Q4 OF 2017 WAS $16.2 MILLION.CERUS CORP - EXPECTS FULL YEAR 2017 PRODUCT REVENUE TO BE $43.6 MILLION.CERUS CORPORATION ANNOUNCES PRELIMINARY PRODUCT REVENUE RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017.  Full Article

Cerus Corp reports Q3 loss per share $0.12
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Cerus Corp :Cerus Corp reports third quarter 2017 results.Q3 loss per share $0.12.Q3 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S.Cerus Corp - ‍product revenue for q3 of 2017 was $10.8 million, up 6 pct compared to $10.2 million recognized during same period in 2016​.  Full Article

Cerus and Kedrion Biopharma enter distribution agreement for full INTERCEPT blood system portfolio
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Cerus Corp :Cerus and Kedrion Biopharma enter distribution agreement for the full INTERCEPT blood system portfolio in Italy.Says ‍entered into an agreement with Kedrion Biopharma to distribute full complement of INTERCEPT blood system products in italy​.Says ‍Kedrion Biopharma will be sole distributor for intercept blood systems in Italy​.Says ‍kedrion Biopharma will have right to distribute INTERCEPT red blood cells following CE mark approval​.  Full Article

Cerus announces agreement with transfusion Center of the Community of Madrid
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Cerus Corp :Cerus announces agreement with transfusion Center of the Community of Madrid.Entered into a supply agreement with Centro de transfusión de la Comunidad de Madrid (CTCM) for intercept blood system for platelets​.  Full Article